IκBβ attenuates angiotensin II-induced cardiovascular inflammation and fibrosis in mice

Hypertension

Volumn 58, Issue 2, 2011, Pages 310-316

  Xu, Shanqin ^a   Zhi, Hui ^a,b   Hou, Xiuyun ^a   Cohen, Richard A ^a   Jiang, Bingbing ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fibrosis; inflammation; iron; NF B; tissue inhibitor of metalloproteinase

Indexed keywords

ANGIOTENSIN II; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COMPLEMENTARY DNA; FIBRONECTIN; HEMOSIDERIN; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR INFLAMMATION; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART MUSCLE FIBROSIS; HYPERTENSION; INTERSTITIUM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CYTOKINES; FIBROSIS; HYPERTENSION; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; MICE; MICE, KNOCKOUT; MYOCARDIUM;

EID: 80051474680     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.172031     Document Type: Article

References (35)

1. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res. 1992;26:671-677.
2. Diez J. Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich). 2007;9:546-550.
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
4. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension. 2004;43:739-745. (Pubitemid 38405580)
5. Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1-induced gene expression. J Biol Chem. 2004;279: 1323-1329. (Pubitemid 38082657)
6. Jiang B, Xu S, Hou X, Pimentel DR, Cohen RA. Angiotensin II differentially regulates interleukin-1-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J Biol Chem. 2004;279:20363-20368. (Pubitemid 38623482)
7. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071. (Pubitemid 27163860)
8. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92:827-839. (Pubitemid 36542523)
9. Ghosh S, Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 1990;344:678-682.
10. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 1999;18:6867-6874.
11. Cheng JD, Ryseck RP, Attar RM, Dambach D, Bravo R. Functional redundancy of the nuclear factor kappa B inhibitors I kappa B and I kappa B. J Exp Med. 1998;188:1055-1062. (Pubitemid 28443329)
12. Beg AA, Sha WC, Bronson RT, Baltimore D. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B-deficient mice. Genes Dev. 1995;9:2736-2746. (Pubitemid 3009953)
13. Mizgerd JP, Scott ML, Spieker MR, Doerschuk CM. Functions of IkappaB proteins in inflammatory responses to Escherichia coli LPS in mouse lungs. Am J Respir Cell Mol Biol. 2002;27:575-582. (Pubitemid 35301812)
14. Fan C, Li Q, Zhang Y, Liu X, Luo M, Abbott D, Zhou W, Engelhardt JF. IkappaB and Ikappa B possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J Clin Invest. 2004;113:746-755. (Pubitemid 38544168)
15. Ishizaka N, Saito K, Noiri E, Sata M, Ikeda H, Ohno A, Ando J, Mori I, Ohno M, Nagai R. Administration of ANG II induces iron deposition and upregulation of TGF-1 mRNA in the rat liver. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1063-R1070. (Pubitemid 40404184)
16. Saito K, Ishizaka N, Aizawa T, Sata M, Iso-o N, Noiri E, Mori I, Ohno M, Nagai R. Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-1 in the heart. Am J Physiol Heart Circ Physiol. 2005;288:H1836-H1843. (Pubitemid 40418011)
17. Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension. 2004;43: 499-503. (Pubitemid 38174161)
18. Weber KT, Brilla CG, Campbell SE, Guarda E, Zhou G, Sriram K. Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol. 1993;88(suppl 1):107-124. (Pubitemid 23226442)
19. Ishizaka N, Saito K, Mori I, Matsuzaki G, Ohno M, Nagai R. Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats. Arterioscler Thromb Vasc Biol. 2005;25:2282-2288. (Pubitemid 41552643)
20. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res. 2001;88:947-953. (Pubitemid 32441474)
21. Jiang B, Haverty M, Brecher P. N-Acetyl-L-cysteine enhances interleukin-1-induced nitric oxide synthase expression. Hypertension. 1999;34:574-579. (Pubitemid 29496436)
22. Bayat H, Xu S, Pimentel D, Cohen RA, Jiang B. Activation of thromboxane receptor upregulates interleukin (IL)-1-induced VCAM-1 expression through JNK signaling. Arterioscler Thromb Vasc Biol. 2008; 28:127-134.
23. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99-109.
24. Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, Bariety J, Michel JB. Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest. 1994;70:286-294. (Pubitemid 24090112)
25. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, Gillijns H, Herijgers P, Flameng W, Carmeliet P, Van de Werf F, Pinto YM, Janssens S. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation. 2005;112:1136-1144. (Pubitemid 41216120)
26. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Fukui H. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology. 2002;36:850-860.
27. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology. 2000;32:1248-1254.
28. Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal. 2008;1:re6.
29. Wilczynska KM, Gopalan SM, Bugno M, Kasza A, Konik BS, Bryan L, Wright S, Griswold-Prenner I, Kordula T. A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes. J Biol Chem. 2006;281:34955-34964. (Pubitemid 46036534)
30. Le Bail O, Schmidt-Ullrich R, Israel A. Promoter analysis of the gene encoding the I kappa B-/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 1993;12: 5043-5049. (Pubitemid 23358492)
31. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S. I kappa B-regulates the persistent response in a biphasic activation of NF-kappa B. Cell. 1995;80:573-582.
32. Wu C, Ghosh S. Differential phosphorylation of the signal-responsive domain of I kappa B and I kappa B by I kappa B kinases. J Biol Chem. 2003;278:31980-31987. (Pubitemid 37048386)
33. Johnson DR, Douglas I, Jahnke A, Ghosh S, Pober JS. A sustained reduction in IkappaB-may contribute to persistent NF-kappaB activation in human endothelial cells. J Biol Chem. 1996;271:16317-16322. (Pubitemid 26236254)
34. Bourke E, Kennedy EJ, Moynagh PN. Loss of Ikappa B-is associated with prolonged NF-kappa B activity in human glial cells. J Biol Chem. 2000;275:39996-40002. (Pubitemid 32064622)
35. Jiang B, Brecher P, Cohen RA. Persistent activation of nuclear factorkappaB by interleukin-1 and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler Thromb Vasc Biol. 2001;21:1915-1920. (Pubitemid 34219741)